Clinical Trials Directory

Trials / Completed

CompletedNCT05608902

Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study (DOCTOBA)

Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Centre Hospitalier William Morey - Chalon sur Saône · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Basal cell carcinoma (BCC) are the most frequent skin cancers. Their incidence is constantly increasing. BCC diagnosis is first clinically suspected and then confirmed following histological examination of either a skin biopsy or the excisional specimen. Surgery is the first-line treatment and some procedures (notably Mohs surgery) require extemporaneous histological analysis of the edges to ensure a complete excision. Such on-site histopathological examination can be time consuming and associated with decreased sensitivity. Skin imaging techniques have already been tested to overcome these limitations and seem promising. Although some of them - such as confocal microscopy - are already even used in vivo, there is to date no report of the use of full-field optical coherence tomography for the diagnosis of BCC. The DOCTOBA study intends to describe direct histopathological examination of fresh skin biopsy or excisional specimen with dynamic full-field optical coherence tomography.

Conditions

Interventions

TypeNameDescription
OTHERDynamic full-field optical coherence tomography analysis of skin biopsy or resectionDynamic full-field optical coherence tomography analysis of skin biopsy or resection in the dermatology department before conventional histopathological analysis

Timeline

Start date
2022-09-06
Primary completion
2023-01-26
Completion
2023-03-31
First posted
2022-11-08
Last updated
2024-01-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05608902. Inclusion in this directory is not an endorsement.